These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37170462)

  • 21. In vitro and in vivo antimalarial activities of T-2307, a novel arylamidine.
    Kimura A; Nishikawa H; Nomura N; Mitsuyama J; Fukumoto S; Inoue N; Kawazu S
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2191-3. PubMed ID: 22252809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarial and antioxidant activities of Indigofera oblongifolia on Plasmodium chabaudi-induced spleen tissue injury in mice.
    Lubbad MY; Al-Quraishy S; Dkhil MA
    Parasitol Res; 2015 Sep; 114(9):3431-8. PubMed ID: 26109255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N1-acetyl-N2-formyl-5-methoxykynuramine modulates the cell cycle of malaria parasites.
    Budu A; Peres R; Bueno VB; Catalani LH; Garcia CR
    J Pineal Res; 2007 Apr; 42(3):261-6. PubMed ID: 17349024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium chabaudi chabaudi: effect of low parasitemias on immunity in CB6F1 mice.
    Favila-Castillo L; Monroy-Ostria A; Garcia-Tapia D
    Exp Parasitol; 1999 May; 92(1):73-80. PubMed ID: 10329368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the activity of N-89 as an oral antimalarial drug.
    Aly NSM; Matsumori H; Dinh TQ; Sato A; Miyoshi SI; Chang KS; Yu HS; Kubota T; Kurosaki Y; Cao DT; Rashed GA; Kim HS
    Parasites Hosts Dis; 2023 Aug; 61(3):282-291. PubMed ID: 37648233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ICAM-1 is a key receptor mediating cytoadherence and pathology in the Plasmodium chabaudi malaria model.
    Cunningham DA; Lin JW; Brugat T; Jarra W; Tumwine I; Kushinga G; Ramesar J; Franke-Fayard B; Langhorne J
    Malar J; 2017 May; 16(1):185. PubMed ID: 28468674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential Plasmodium chabaudi and Plasmodium berghei infections provide a novel model of severe malarial anemia.
    Harris JV; Bohr TM; Stracener C; Landmesser ME; Torres V; Mbugua A; Moratz C; Stoute JA
    Infect Immun; 2012 Sep; 80(9):2997-3007. PubMed ID: 22689817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stromal cell derived factor 1 synthesis by spleen cells in rodent malaria, and the effects of in vivo supplementation of SDF-1alpha and CXCR4 receptor blocker.
    Garnica MR; Souto JT; Silva JS; de Andrade HF
    Immunol Lett; 2002 Aug; 83(1):47-53. PubMed ID: 12057854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.
    Rummel T; Batchelder J; Flaherty P; LaFleur G; Nanavati P; Burns JM; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5768-74. PubMed ID: 15385476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electron tomography characterization of hemoglobin uptake in Plasmodium chabaudi reveals a stage-dependent mechanism for food vacuole morphogenesis.
    Wendt C; Rachid R; de Souza W; Miranda K
    J Struct Biol; 2016 May; 194(2):171-9. PubMed ID: 26882843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimalarial activity of vitamin D3 (VD3) does not result from VD3-induced antimicrobial agents including nitric oxide or cathelicidin.
    Yamamoto K; Takahashi K; Ato M; Iwanaga S; Ohta N
    Exp Parasitol; 2019 Jun; 201():67-77. PubMed ID: 30904694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).
    Satish PVV; Sunita K
    BMC Complement Altern Med; 2017 Sep; 17(1):458. PubMed ID: 28893216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Evaluation of Two Novel Antimalarial Derivatives of SKM13: SKM13-MeO and SKM13-F.
    Trinh TT; Kim YA; Hong H; Le LTT; Jang H; Kim SA; Park H; Kim HS; Yeo SJ
    Korean J Parasitol; 2022 Dec; 60(6):401-407. PubMed ID: 36588416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental stages influence in vivo antimalarial activity of aerial part extracts of Schkuhria pinnata.
    Nuwagira C; Peter EL; Ajayi CO; Adriko J; Kagoro GR; Olet EA; Ogwang PE; Tolo CU
    J Ethnopharmacol; 2021 Oct; 279():114341. PubMed ID: 34144195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential induction of malaria liver pathology in mice infected with Plasmodium chabaudi AS or Plasmodium berghei NK65.
    Scaccabarozzi D; Deroost K; Corbett Y; Lays N; Corsetto P; Salè FO; Van den Steen PE; Taramelli D
    Malar J; 2018 Jan; 17(1):18. PubMed ID: 29316914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of Plasmodium berghei parasitemia by LiCl in an animal infection model.
    Nurul Aiezzah Z; Noor E; Hasidah MS
    Trop Biomed; 2010 Dec; 27(3):624-31. PubMed ID: 21399604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surfaces of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro.
    Mota MM; Brown KN; Holder AA; Jarra W
    Infect Immun; 1998 Sep; 66(9):4080-6. PubMed ID: 9712751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.